Private debt, infrastructure remain top picks for Korean LPs in 2024

Private debt and infrastructure will remain South Korean institutional investors’ favorite alternative asset classes for the second straight yea...
Private debt and infrastructure will remain South Korean institutional investors’ favorite alternative asset classes for the second straight yea...
South Korea's bioplasma technology firm Plasmapp announced on Friday that it has signed a product supply contract worth 16.4 billion won ($12.3 mill...
As economic uncertainties grow amid rate hikes and inflation, South Korean institutional investors are eyeing direct lending for safer investment an...